 MONTREAL, Jan. 18, 2023 PRNewswire To ensure patient safety remains at the forefront of the work of the World Federation of Hemophilia WFH, we have developed a registry to monitor the long-term safety and efficacy of gene therapy for people with hemophilia: the WFH Gene Therapy Registry GTR. The launch of the WFH GTR... The post WFH Gene Therapy Registry: now live! appeared first on DKODING... 